0001176407-13-000005.txt : 20130911 0001176407-13-000005.hdr.sgml : 20130911 20130911113234 ACCESSION NUMBER: 0001176407-13-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130911 DATE AS OF CHANGE: 20130911 EFFECTIVENESS DATE: 20130911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTRA CELLULAR THERAPIES INC CENTRAL INDEX KEY: 0001176407 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-202684 FILM NUMBER: 131090429 BUSINESS ADDRESS: STREET 1: AUDUBON BIOMEDICAL SCIENCE STREET 2: & TECHNOLOGY PARK, 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: AUDUBON BIOMEDICAL SCIENCE STREET 2: & TECHNOLOGY PARK, 3960 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10032 D 1 primary_doc.xml X0706 D LIVE 0001176407 INTRA CELLULAR THERAPIES INC AUDUBON BIOMEDICAL SCIENCE & TECHNOLOGY PARK, 3960 BROADWAY NEW YORK NY NEW YORK 10032 212-923-3344 DELAWARE None None Corporation true Sharon Mates 3960 Broadway New York NY NEW YORK 10032 Executive Officer Director Allen Fienberg 3960 Broadway New York NY NEW YORK 10032 Executive Officer Lawrence Wennogle 3960 Broadway New York NY NEW YORK 10032 Executive Officer Lawrence Hineline 3960 Broadway New York NY NEW YORK 10032 Executive Officer Kimberly Vanover 3960 Broadway New York NY NEW YORK 10032 Executive Officer Christopher Alafi 3960 Broadway New York NY NEW YORK 10032 Director Richard Lerner 3960 Broadway New York NY NEW YORK 10032 Director Joel Marcus 3960 Broadway New York NY NEW YORK 10032 Director Michael Rawlins 3960 Broadway New York NY NEW YORK 10032 Director Biotechnology Decline to Disclose 06 false 2013-08-29 false true true Reverse Merger will take place after offering. 0 Leerink Swann LLC 39011 None None 1 Federal Street Boston MA MASSACHUSETTS 02110 AZ ARIZONA CA CALIFORNIA DC DISTRICT OF COLUMBIA MA MASSACHUSETTS MO MISSOURI NJ NEW JERSEY NY NEW YORK false National Securities Corporation 7569 None None 120 Broadway New York NY NEW YORK 10271 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MN MINNESOTA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK OK OKLAHOMA OR OREGON PA PENNSYLVANIA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false Livingston Securities, LLC 147364 None None 825 Third Avenue New York NY NEW YORK 10022 AL ALABAMA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA IL ILLINOIS LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI NJ NEW JERSEY NY NEW YORK OH OHIO OR OREGON PA PENNSYLVANIA TN TENNESSEE TX TEXAS VA VIRGINIA WA WASHINGTON WY WYOMING false 60000000 60000000 0 Includes approximately $15.3 million in principal, plus accrued interest, from the conversion of outstanding convertible notes. false 185 2905000 true 0 Will be paid in aggregate cash fee not to exceed $2,905,000. 0 false INTRA CELLULAR THERAPIES INC /s/ Sharon Mates Sharon Mates Founder, Chairman, President and Chief Executive Officer 2013-09-11